ArticleTurkish journal of medical sciences2026
Can hydrolyzed silk fibroin derived from
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: The therapeutic effects of hydrolyzed silk fibroin derived from Materials and methods: A standardized corneal alkali burn was induced in the right eyes of Wistar albino rats using 1 N sodium hydroxide (NaOH). Animals were randomly assigned to six groups: negative control, positive control (PC), hydrolyzed silk fibroin (SF), ozonized gel (O), combined treatment (SF + O), and antibiotic treatment. Topical treatments were administered for 21 consecutive days. Clinical evaluation included assessments of corneal opacity, neovascularization, and epithelial healing. On day 21, corneal tissues were harvested for biochemical analysis of TGF-β, VEGF, and TNF-α levels, as well as for histopathological assessment. Results: Significantly elevated levels of TGF-β, VEGF, and TNF-α were observed in untreated alkali-burned corneas compared with controls (p < 0.001). All treatment groups demonstrated significant reductions in these mediators compared with the PC group (p < 0.001). The SF and O groups showed comparable effects, whereas the SF + O group exhibited the lowest mean VEGF and TNF-α levels among the treatment groups, with no statistically significant difference compared with the antibiotic group (p > 0.05). Histopathological findings were consistent with the biochemical results, demonstrating improved epithelial integrity, reduced inflammatory cell infiltration, and more organized stromal architecture, particularly in the SF + O group. Conclusion: Hydrolyzed silk fibroin derived from
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.